4//SEC Filing
FETZER OLIVER 4
Accession 0001209191-19-037487
CIK 0001080709other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 6:41 PM ET
Size
11.1 KB
Accession
0001209191-19-037487
Insider Transaction Report
Form 4
FETZER OLIVER
Director
Transactions
- Award
Common Stock
2019-06-13+2,654→ 5,704 total - Sale
Common Stock
2019-06-14$55.88/sh−1,495$83,539→ 4,209 total - Sale
Common Stock
2019-06-14$56.64/sh−30$1,699→ 4,179 total - Award
Stock Option (right to buy)
2019-06-13+5,000→ 5,000 totalExercise: $56.50Exp: 2026-06-13→ Common Stock (5,000 underlying)
Footnotes (4)
- [F1]The amount represents restricted stock units that vest in full on the earliest of June 13, 2020, or the date of Arena's next annual meeting of stockholders. The shares underlying the restricted stock units will be issued upon vesting of the restricted stock units.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.49 to $56.48, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4.
- [F4]The options vest in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on July 13, 2019, and are exercisable once vested.
Documents
Issuer
ARENA PHARMACEUTICALS INC
CIK 0001080709
Entity typeother
Related Parties
1- filerCIK 0001219018
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 6:41 PM ET
- Size
- 11.1 KB